Sun Pharmaceutical Industries

Upon the completion of merger Taro will become a privately held company wholly owned by Sun Pharma

Winlevi is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older

Over 9,400 companies were assessed for The Sustainability Yearbook 2024. Out of these, 739 companies have qualified for inclusion…

Sun Pharma to market the drug under the brand name Lyvelsa

Intratumoral Nidlegy followed by surgery significantly improved the Recurrence-Free Survival compared to surgery alone

Researchers reported that CEQUA elicited significant improvement in corneal fluorescein staining and in mSANDE scores in patients…

Deuruxolitinib is being evaluated for treatment of moderate to severe alopecia areata

Sovateltide is indicated for treating cerebral ischemic stroke

In China clinical studies, the PASI 75 response rate reached a high level after 28 weeks of treatment with ILUMETRI and maintained…

The company is recalling the affected lot due to the presence of particulate matter